AC   CVCL_5362
DR   CLO; CLO_0051566
DR   BioSample; SAMN03472315
DR   RCB; RCB0441
DR   Wikidata; Q54952384
RX   PubMed=1373668;
RX   PubMed=7536509;
CC   Population: Japanese.
CC   Doubling time: 24.4 hours (PubMed=1373668).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): RCB=RCB0441
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
RX   PubMed=1373668; DOI=10.1002/1097-0142(19920515)69:10<2589::AID-CNCR2820691032>3.0.CO;2-Y;
RA   Urade M., Ogura T., Mima T., Matsuya T.;
RT   "Establishment of human squamous carcinoma cell lines highly and
RT   minimally sensitive to bleomycin and analysis of factors involved in
RT   the sensitivity.";
RL   Cancer 69:2589-2597(1992).
RX   PubMed=7536509; DOI=10.1016/0964-1955(94)90021-3;
RA   Urade M., Ogura T., Uematsu T., Takahashi Y., Kishimoto H.,
RA   Yoshioka W.;
RT   "Induction of bleomycin resistance in a human oral squamous carcinoma
RT   cell line and characterisation of bleomycin-resistant and -sensitive
RT   clones.";
RL   Eur. J. Cancer B Oral Oncol. 30:409-414(1994).